Cargando…
Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?
SIMPLE SUMMARY: Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of abnormal B lymphocytes in the peripheral components of the immune system. Despite the development of new therapies for CLL, drug resistance and disease relapse still occur. In the bone marrow and secondary lym...
Autores principales: | Dubois, Kenza, Tannoury, Mariana, Bauvois, Brigitte, Susin, Santos A., Garnier, Delphine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137283/ https://www.ncbi.nlm.nih.gov/pubmed/37190234 http://dx.doi.org/10.3390/cancers15082307 |
Ejemplares similares
-
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?
por: Tannoury, Mariana, et al.
Publicado: (2022) -
Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway
por: Bauvois, Brigitte, et al.
Publicado: (2021) -
Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia
por: Bauvois, Brigitte, et al.
Publicado: (2020) -
The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?
por: Bauvois, Brigitte, et al.
Publicado: (2023) -
Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?
por: Bauvois, Brigitte, et al.
Publicado: (2018)